UK Innovation & Science Seed Fund

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Ikarovec is a gene therapy company focused on developing early-stage treatments for common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, working on therapies that also target dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By advancing these innovative treatments, Ikarovec seeks to provide effective solutions for patients, helping to restore sight and prevent blindness.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

Antiverse is an innovative antibody discovery company that aims to transform drug development by leveraging a unique platform combining structural biology, machine learning, and medicine. The company specializes in predicting antibody-antigen binding and generating antibody drug candidates for challenging targets. By utilizing advanced machine learning techniques and cell-free protein synthesis, Antiverse enables pharmaceutical companies and contract research organizations to accelerate the discovery of antibody hits, ultimately making the drug development process more efficient and cost-effective. Through its commitment to advancing medical science, Antiverse seeks to create meaningful breakthroughs that can significantly impact patient lives.

Aquark Technologies specializes in the development of compact cold atom systems aimed at advancing quantum applications, such as atomic clocks, sensors, and navigation systems. The company has pioneered a method to miniaturize these systems using innovative laser geometry, building on over a decade of proprietary research conducted at the University of Southampton. By creating plug-and-play cold-atom quantum devices that are comparable in size to a matchbox, Aquark Technologies offers clients portable and scalable solutions, facilitating the integration of quantum technologies into everyday life and positioning itself at the forefront of the next generation of quantum sensing and computing.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

HonuWorx is a technology company specializing in autonomous subsea robotics. It develops unmanned marine systems designed to deploy and control robots for offshore work, reducing reliance on large manned vessels. The company's edge-cloud architected software platform enables real-time data sharing, collaboration, supervision, and control of robotic systems beyond line-of-sight. This technology lowers operational expenses and environmental impact by minimizing travel requirements offshore, facilitating sustainable commercialization of ocean resources.

Adamo Foods is a UK-based food technology company specializing in the development of plant-based whole-cut meats. Utilizing proprietary fermentation technology alongside mycelium, the company produces sustainable steak and other meat alternatives. Adamo Foods aims to provide functional meat proteins through precision fermentation, offering consumers an efficient, sustainable, and ethical food option that does not compromise on taste or experience.

Wave Photonics is a company based in Cambridge, UK, focused on enhancing the design and integration of integrated photonics products. It develops a platform that utilizes computational techniques to optimize product designs and streamline the supply chain. This platform offers a software tool that predicts the performance and variability of components based on specific fabrication processes, along with an optimizer to create a library of foundry-specific components. By facilitating the development and mass production of integrated photonics technologies, Wave Photonics aims to improve efficiency and reduce redundancy for businesses in the sector.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

ExactTrak is a cybersecurity company specializing in the design and development of software aimed at protecting mobile data during transit. The company creates solutions that are integrated into various hardware, including USB memory products and laptops, to safeguard sensitive information. ExactTrak also provides a managed service that combines its patented technology with mobile data security services, addressing the challenges of data loss and human error. This offering helps organizations comply with legal obligations and mitigate risks associated with data protection violations, thereby preventing potential fines and damage to their reputation. Furthermore, ExactTrak has established a development agreement with a prominent processor manufacturer to incorporate its technology into future generations of professional processors, enhancing the security features of these devices.

HutanBio is a biotechnology company focused on producing sustainable biofuels derived from algae. The firm specializes in developing HBx bio-oil, which is characterized by its high energy density, low carbon footprint, and absence of sulfur. HutanBio's innovative approach allows for scalable production through its algal farms, catering to various sectors, including marine, land, and aviation. By providing a drop-in replacement fuel, the company enables its clients to reduce emissions and comply with environmental regulations, contributing to a more sustainable energy landscape.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

MitoRx Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company specializes in creating mitochondrial-protective treatments for a range of conditions, including neuromuscular disorders, metabolic diseases, and dementia. By targeting the underlying mitochondrial issues associated with these challenging diseases, MitoRx Therapeutics seeks to enable healthcare professionals to halt the progression of conditions such as dystrophy and neurodegeneration. In addition to its internal research on rare indications, the company also collaborates on broader health issues, positioning itself as a key player in the field of mitochondrial medicine.

Laverock Therapeutics is focused on advancing a gene silencing platform that facilitates the development of programmable, allogeneic cell therapies. This innovative platform allows for the engineering of next-generation cell therapies that are both adaptive and capable of responding to various intra- and extra-cellular environmental cues. By enhancing the functionality of these therapies, Laverock Therapeutics aims to improve the efficacy, safety, and accessibility of iPSC-derived products, addressing significant limitations associated with current therapeutic approaches. The company's work is positioned to benefit medical and biotechnology institutions seeking to leverage advanced cell therapy solutions.

Pencil Biosciences is focused on advancing gene-editing technology through the development of a novel, programmable genome-modulation platform. This innovative approach seeks to address the limitations of existing gene-editing technologies, providing new therapeutic options for patients with rare diseases. By enhancing the precision and efficacy of genome modulation, Pencil Biosciences aims to facilitate a wide range of applications in the medical field, ultimately supporting healthcare professionals in overcoming the challenges associated with traditional gene-editing methods.

Laverock Therapeutics is focused on advancing a gene silencing platform that facilitates the development of programmable, allogeneic cell therapies. This innovative platform allows for the engineering of next-generation cell therapies that are both adaptive and capable of responding to various intra- and extra-cellular environmental cues. By enhancing the functionality of these therapies, Laverock Therapeutics aims to improve the efficacy, safety, and accessibility of iPSC-derived products, addressing significant limitations associated with current therapeutic approaches. The company's work is positioned to benefit medical and biotechnology institutions seeking to leverage advanced cell therapy solutions.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

NK:IO is a biotechnology company focused on advancing innovative strategies for natural killer cell-mediated immunotherapy. It specializes in the development of both cell therapies and small molecule therapeutics, with a primary emphasis on cancer treatment. By harnessing the capabilities of natural killer cells, NK:IO aims to enhance the effectiveness of cancer therapies, providing physicians with improved tools to combat the disease. The company's commitment to research and development positions it at the forefront of immunotherapy advancements in the oncology field.

Resurrect Bio is a plant biotechnology company focused on enhancing the immune systems of various crop species. By leveraging innovative resistance genes, the company aims to combat plant diseases effectively, ultimately assisting farmers in cultivating healthier crops. Its mission is to revolutionize the agricultural industry by improving crop resilience, promoting sustainable farming practices, and ensuring greater food security. Through its advancements in biotechnology, Resurrect Bio seeks to address critical challenges faced by farmers and contribute to the overall improvement of agricultural productivity.

HydRegen is a biotechnology company founded in 2020 and headquartered in Oxford, United Kingdom. The company specializes in providing sustainable solutions for chemical manufacturing through the development of bio-based manufacturing technologies. Utilizing innovative biocatalysis techniques, HydRegen aims to enhance agility, speed, and predictability during the early stages of industrial research and development. This approach enables the chemicals and pharmaceutical sectors to validate their processes while meeting essential requirements for cost, productivity, and reproducibility at scale.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Silicon Microgravity Limited is a technology company based in Cambridge, United Kingdom, that specializes in developing advanced sensor devices for the oil and gas sector. Established in 2014 as a spin-out from Cambridge University, the company has created innovative microelectromechanical system sensors that enable high-sensitivity gravity data recording and seismic data capture at ultra-low frequencies. This technology, initially developed in collaboration with BP plc and funded by Innovate UK, represents a significant advancement in oil and gas reservoir management. By transforming how density measurements are taken deep within reservoirs, Silicon Microgravity aims to enhance reservoir surveillance and improve operational efficiencies, allowing clients to achieve cost savings while adhering to social, safety, and environmental standards. The company's technology also has applications in navigation, guidance, and the stabilization of intelligent systems across various sectors, including commercial, industrial, and military uses.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

Productive Machines is a company that specializes in software optimization services for the machining industry, focusing on enhancing productivity and sustainability for manufacturers. By leveraging a digital twin of the machining process, which simulates the physics, mechanics, dynamics, distortion, and vibration involved in metal cutting, Productive Machines enables manufacturers to test millions of parameters in a virtual environment. This innovative approach allows for improved Computer-Aided Manufacturing (CAM) and Gcode, effectively eliminating chatter vibrations, reducing cycle times, minimizing tooling costs, and enhancing surface finish and dimensional accuracy. As a spin-out from the UK Advanced Manufacturing Research Centre, Productive Machines aims to streamline machining processes, empowering companies to achieve higher quality parts more efficiently and cost-effectively.

Sugarox specializes in the development of biostimulants that support farmers in enhancing agricultural productivity and resilience. The company's products are designed to optimize the output of each unit of land while improving the ability of crop systems to withstand challenging weather conditions, such as drought. By focusing on increasing productivity, profitability, efficiency, and sustainability, Sugarox aims to empower farmers to achieve better results in their crop production efforts.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Silveray is a company focused on developing affordable large-area direct conversion detectors specifically for the X-ray imaging market. It leverages advanced core technology that delivers high-performance X-ray imaging through the use of nanoparticle-based X-ray conversion materials. These materials are produced as a semiconductor ink, which is then deposited onto a pixel backplane. This innovative approach enables healthcare providers and various industries to generate an electrical current response to detected X-ray photons, all while maintaining a sustainable cost point. Silveray aims to enhance the efficiency and accessibility of X-ray imaging solutions.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

MitoRx Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company specializes in creating mitochondrial-protective treatments for a range of conditions, including neuromuscular disorders, metabolic diseases, and dementia. By targeting the underlying mitochondrial issues associated with these challenging diseases, MitoRx Therapeutics seeks to enable healthcare professionals to halt the progression of conditions such as dystrophy and neurodegeneration. In addition to its internal research on rare indications, the company also collaborates on broader health issues, positioning itself as a key player in the field of mitochondrial medicine.

Q5D is an innovative company specializing in the automation of manufacturing and assembly processes for wiring looms. It develops advanced tools and laser micromachining technology that streamline the intricate connections of electric components. Q5D's solutions cater to various industrial sectors, including automotive, aerospace, consumer electronics, and robotics. By enabling the direct addition of wire and printed electronics onto product surfaces, the company enhances manufacturing quality, productivity, and functionality while simultaneously lowering production costs. This technology provides clients with a competitive advantage in achieving efficiency, resilience, and sustainability in their operations.

Atheras Analytics is a developer of AI-based software tools tailored for the design and operation of Ka-band and Q/V-band satellite networks. The company focuses on mitigating weather-related impacts and enhancing network and service availability. Utilizing advanced machine-learning algorithms, Atheras Analytics leverages a comprehensive database of satellite signal propagation time-series measurements and high-resolution data. This innovative approach enables satellite operators to optimize the design of multi-gateway satellite networks, ultimately facilitating more cost-effective solutions in the industry.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

NanoSyrinx is an innovative biotechnology company focused on advancing targeted drug delivery systems for therapeutic proteins and peptides. Utilizing synthetic biology techniques, the company has developed a unique method to deliver these biologics directly to the cytosol of cells, enhancing the efficacy and safety of treatments. By aiming to improve treatment outcomes for patients, NanoSyrinx positions itself within the biopharmaceutical sector, addressing critical needs in the delivery of therapeutic agents. The company's novel approach seeks to transform how medications are administered at the cellular level, ultimately contributing to more effective and economical healthcare solutions.

AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Antiverse is an innovative antibody discovery company that aims to transform drug development by leveraging a unique platform combining structural biology, machine learning, and medicine. The company specializes in predicting antibody-antigen binding and generating antibody drug candidates for challenging targets. By utilizing advanced machine learning techniques and cell-free protein synthesis, Antiverse enables pharmaceutical companies and contract research organizations to accelerate the discovery of antibody hits, ultimately making the drug development process more efficient and cost-effective. Through its commitment to advancing medical science, Antiverse seeks to create meaningful breakthroughs that can significantly impact patient lives.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

NanoSyrinx is an innovative biotechnology company focused on advancing targeted drug delivery systems for therapeutic proteins and peptides. Utilizing synthetic biology techniques, the company has developed a unique method to deliver these biologics directly to the cytosol of cells, enhancing the efficacy and safety of treatments. By aiming to improve treatment outcomes for patients, NanoSyrinx positions itself within the biopharmaceutical sector, addressing critical needs in the delivery of therapeutic agents. The company's novel approach seeks to transform how medications are administered at the cellular level, ultimately contributing to more effective and economical healthcare solutions.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Ikarovec is a gene therapy company focused on developing early-stage treatments for common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, working on therapies that also target dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By advancing these innovative treatments, Ikarovec seeks to provide effective solutions for patients, helping to restore sight and prevent blindness.

Pencil Biosciences is focused on advancing gene-editing technology through the development of a novel, programmable genome-modulation platform. This innovative approach seeks to address the limitations of existing gene-editing technologies, providing new therapeutic options for patients with rare diseases. By enhancing the precision and efficacy of genome modulation, Pencil Biosciences aims to facilitate a wide range of applications in the medical field, ultimately supporting healthcare professionals in overcoming the challenges associated with traditional gene-editing methods.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

C-Major Medical is dedicated to addressing the persistent issue of needlestick injuries (NSIs) in medical environments. Established with the goal of enhancing safety for healthcare workers, the company develops innovative syringe and blood collection systems specifically designed to minimize the risk of NSIs and associated contaminating aerosols. By focusing on the creation of advanced safety devices, C-Major Medical aims to provide hospitals, clinics, and medical practitioners with effective solutions to protect staff and improve overall safety in clinical settings. Despite efforts and legislation over the years, NSI incidents have not significantly decreased, underscoring the necessity for C-Major Medical's contributions to the healthcare industry.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Procarta Biosystems Ltd is a biotechnology company based in Norwich, United Kingdom, that specializes in the development of innovative DNA-based antibacterials. Founded in 2007 as a spin-out from the John Innes Centre, Procarta focuses on addressing the critical challenge of drug-resistant bacterial strains, commonly referred to as superbugs. The company has created a versatile platform for antibiotic development, which includes proprietary nanoparticles designed to deliver oligonucleotides directly into bacterial pathogens. Their product range features targeted therapies such as MRSA snare, a solution for both topical and intravenous use; Broad-spectrum Gram-negative therapy snare, aimed at treating hospital-acquired infections; and Cdiff snare, which helps prevent the recurrence of Clostridium difficile infections. With a commitment to combating the rising threat of antibiotic resistance, Procarta Biosystems is positioned to enhance therapeutic options in clinical settings.

Eagle Genomics is an enterprise software solutions company specializing in the management and analysis of genomics and life sciences data. Its innovative platform facilitates the curation, integration, sharing, and analysis of scientific data, thereby enhancing productivity and reducing costs and time in research and development. By transforming data sets into valuable assets, the company redefines how digital information is measured and utilized, providing insights into the return on information. With a unique blend of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics addresses the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech, particularly in managing the increasing volume of data. The company is positioned at the forefront of delivering the essential information architecture needed for the genomics era, helping clients navigate the complexities of data-driven research and development.

Antiverse is an innovative antibody discovery company that aims to transform drug development by leveraging a unique platform combining structural biology, machine learning, and medicine. The company specializes in predicting antibody-antigen binding and generating antibody drug candidates for challenging targets. By utilizing advanced machine learning techniques and cell-free protein synthesis, Antiverse enables pharmaceutical companies and contract research organizations to accelerate the discovery of antibody hits, ultimately making the drug development process more efficient and cost-effective. Through its commitment to advancing medical science, Antiverse seeks to create meaningful breakthroughs that can significantly impact patient lives.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Glialign is focused on advancing innovative cell therapies aimed at repairing peripheral nerves, a critical area where existing treatments often fall short, achieving success in less than half of cases. The company has developed regenerative technologies that facilitate surgeries involving living neural tissue. Its primary product is a living nerve growth guide designed for peripheral nerve repair, serving as an effective, off-the-shelf alternative to traditional nerve allografts. This technology eliminates the need for a secondary surgical procedure to harvest nerves from other body parts, thereby streamlining the treatment process. By enabling healthcare providers to guide nerve regeneration, Glialign aims to enhance recovery outcomes for patients suffering from nerve injuries.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Eagle Genomics is an enterprise software solutions company specializing in the management and analysis of genomics and life sciences data. Its innovative platform facilitates the curation, integration, sharing, and analysis of scientific data, thereby enhancing productivity and reducing costs and time in research and development. By transforming data sets into valuable assets, the company redefines how digital information is measured and utilized, providing insights into the return on information. With a unique blend of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics addresses the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech, particularly in managing the increasing volume of data. The company is positioned at the forefront of delivering the essential information architecture needed for the genomics era, helping clients navigate the complexities of data-driven research and development.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Procarta Biosystems Ltd is a biotechnology company based in Norwich, United Kingdom, that specializes in the development of innovative DNA-based antibacterials. Founded in 2007 as a spin-out from the John Innes Centre, Procarta focuses on addressing the critical challenge of drug-resistant bacterial strains, commonly referred to as superbugs. The company has created a versatile platform for antibiotic development, which includes proprietary nanoparticles designed to deliver oligonucleotides directly into bacterial pathogens. Their product range features targeted therapies such as MRSA snare, a solution for both topical and intravenous use; Broad-spectrum Gram-negative therapy snare, aimed at treating hospital-acquired infections; and Cdiff snare, which helps prevent the recurrence of Clostridium difficile infections. With a commitment to combating the rising threat of antibiotic resistance, Procarta Biosystems is positioned to enhance therapeutic options in clinical settings.

SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

C-Major Medical is dedicated to addressing the persistent issue of needlestick injuries (NSIs) in medical environments. Established with the goal of enhancing safety for healthcare workers, the company develops innovative syringe and blood collection systems specifically designed to minimize the risk of NSIs and associated contaminating aerosols. By focusing on the creation of advanced safety devices, C-Major Medical aims to provide hospitals, clinics, and medical practitioners with effective solutions to protect staff and improve overall safety in clinical settings. Despite efforts and legislation over the years, NSI incidents have not significantly decreased, underscoring the necessity for C-Major Medical's contributions to the healthcare industry.

MyoDOPA is develops a novel therapeutic profile providing efficient treatment.

Camstech Ltd, founded in 2014 by Professor Pankaj Vadgama, specialises in developing innovative biochemical sensing technologies. Initially incubated at CERN's Business Incubation Centre and now based at STFC's Campus Technology Hub, Daresbury Laboratory, the company aims to commercialise novel sensing technology initially for life sciences research, with potential applications in biotechnology and medical diagnostics. Camstech focuses on creating advanced electrochemical sensors featuring novel electrodes that offer improved stability and resistance to biofouling compared to conventional screen-printed electrodes, enabling continuous monitoring and facilitating the development of tests for emerging markers by biotechnology companies.

Cagen is a synthetic biology company.

Pireta Ltd, established in 2017 and headquartered in Teddington, UK, specializes in developing and commercializing smart textile technology. The company's core business involves creating an additive process that imparts conductivity and sensors to fabrics at any stage of manufacturing, without altering their handle or drape. Pireta's innovative textiles are used across various industries, including military and defense, healthcare, fashion, athletics, and RFID tagging, enabling communication, physiological measurement tracking, and electronic system integration on a wide range of fabrics.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Puraffinity Ltd., established in London in 2015, specialises in innovative water treatment solutions. The company designs and develops precision materials, notably a sustainable adsorbent capable of removing challenging pollutants like pesticides, pharmaceuticals, and PFAS from contaminated water and wastewater. Utilising advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals selectively, enabling clients to meet stringent regulations and protect local ecosystems sustainably.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Nemesis Bioscience Ltd., established in 2014 and headquartered in Cambridge, UK, specializes in developing and commercializing innovative therapeutic agents. The company's core focus is to restore the effectiveness of existing antibiotics against currently resistant microbial pathogens. Nemesis Bioscience achieves this through its symbiotics, which directly kill pathogenic microorganisms and/or sensitize them to currently available antibiotics. The company's solutions are employed to treat infections and prevent patients from acquiring potentially life-threatening resistant pathogens. Nemesis Bioscience has been recognized for its work, having received the King's College, Cambridge Entrepreneurship Award in 2014, and has filed international patent applications for its inventions.

The Electrospinning Company Ltd. specializes in designing, developing, and manufacturing innovative biomaterials for regenerative medical applications and 3D cell culture products. Founded in 2008 and located in Didcot, United Kingdom, the company offers a range of products including aligned fiber scaffolds, plates with removable scaffold discs, and tissue culture plates. These biomaterials are synthetic polymer-based and are designed to mimic the human body's natural extracellular matrix, facilitating post-surgery recovery and supporting tissue-engineering efforts. In addition to its product offerings, The Electrospinning Company provides a variety of services, such as scaffold design, development of sterilization protocols, packaging solutions, and regulatory support for clinical trials. The company also collaborates with academic researchers to develop novel nanofibre solutions for scientific applications, making it a key player in the fields of tissue engineering, regenerative medicine, and drug discovery. Products are available for purchase online.

AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

Quethera Limited is a biotechnology company based in Canterbury, United Kingdom, focused on developing gene therapy treatments for glaucoma and other ophthalmic diseases. Established in 2013, the company aims to address progressive visual loss associated with these conditions, particularly in patients experiencing accelerated deterioration of their visual fields. Quethera collaborates with leading experts in the field of glaucoma to design and conduct clinical trials that assess the efficacy and safety of its innovative therapies. With a strong foundation in gene therapeutic design and development, Quethera is advancing its pipeline from preclinical testing into clinical development, striving to provide effective treatment solutions for common blinding eye diseases. As of 2018, Quethera operates as a subsidiary of Astellas Pharma Inc.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. By offering a suite of features that can be utilized independently or collectively, NorthRow allows users to conduct thorough checks on individuals and companies, as well as verify identity documents. This capability aids in optimizing business processes, reducing risk, and ensuring compliance with regulatory standards. The platform streamlines onboarding processes and enhances client due diligence by continuously monitoring customer profiles for relevant changes, thereby proactively managing regulatory risks. By leveraging multiple data sources for authentication, NorthRow enables businesses to improve their customer experiences while effectively combating financial crime.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Spectral Edge Ltd, established in 2011 and headquartered in Cambridge, UK, specializes in image enhancement technologies. The company develops innovative solutions such as Phusion, which improves image and video quality by leveraging information outside the visible spectrum, and Eyeteq, a video personalization technology that enhances TV accessibility for color-blind individuals. Spectral Edge's products cater to consumer electronics manufacturers and service providers, serving applications like computational photography, security, and consumer electronics. As of 2019, the company operates as a subsidiary of Apple Inc.

Tokamak Energy Ltd is a private company based in Abingdon, United Kingdom, focused on the development of fusion power technology. Founded in 2009, the company specializes in creating compact and cost-effective fusion power devices, particularly through the use of spherical tokamaks. These innovative reactors are designed to achieve higher plasma pressure with reduced magnetic field requirements compared to traditional tokamaks. Tokamak Energy utilizes high-temperature superconducting magnets to enhance plasma control within its devices, thereby improving efficiency. The company's commitment to rapid innovation leverages advanced materials and technology, building on decades of scientific research. By aiming to develop commercial fusion power solutions, Tokamak Energy contributes to the pursuit of affordable and sustainable energy, addressing global energy security while minimizing environmental impact.

Claresys Ltd. is a company that specializes in the development and supply of lens solutions specifically designed for covert surveillance applications. Its product range includes covert pinhole pan/tilt/zoom lenses suitable for C mount 1/3” sensor cameras, as well as miniature pinhole camera lenses. Claresys also offers custom lens designs tailored for long-range surveillance in challenging environments, such as nuclear and high-temperature fields. The company's optical technologies are utilized in various surveillance contexts, allowing for effective close surveillance in buildings and vehicles, as well as long-distance stake-outs. Primarily serving customers in the defense, homeland security, and police sectors, Claresys markets its products through a network of distributors across several countries, including the United Kingdom, the United States, Australia, and various European nations. Established in 2007 and headquartered in Abingdon, United Kingdom, Claresys aims to provide high-performance optical solutions that enhance both the effectiveness and safety of surveillance operations.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. By offering a suite of features that can be utilized independently or collectively, NorthRow allows users to conduct thorough checks on individuals and companies, as well as verify identity documents. This capability aids in optimizing business processes, reducing risk, and ensuring compliance with regulatory standards. The platform streamlines onboarding processes and enhances client due diligence by continuously monitoring customer profiles for relevant changes, thereby proactively managing regulatory risks. By leveraging multiple data sources for authentication, NorthRow enables businesses to improve their customer experiences while effectively combating financial crime.

Eagle Genomics is an enterprise software solutions company specializing in the management and analysis of genomics and life sciences data. Its innovative platform facilitates the curation, integration, sharing, and analysis of scientific data, thereby enhancing productivity and reducing costs and time in research and development. By transforming data sets into valuable assets, the company redefines how digital information is measured and utilized, providing insights into the return on information. With a unique blend of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics addresses the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech, particularly in managing the increasing volume of data. The company is positioned at the forefront of delivering the essential information architecture needed for the genomics era, helping clients navigate the complexities of data-driven research and development.

Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutics. Established in 2003, the company specializes in small-molecule inhibitors targeting p300, CBP, and specific deubiquitinase enzymes, which play a crucial role in regulating gene expression in cancer cells. Its primary research program addresses prostate cancer, a significant cause of male mortality, by modulating the androgen receptor pathway and potentially overcoming resistance mechanisms found in existing treatments. Additionally, CellCentric's products have applications in treating other cancers, including non-small cell lung cancer, breast cancer, and colon cancer. The company's approach aims to provide targeted therapies for various malignancies, addressing unmet medical needs in the oncology field.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Tokamak Solutions UK Ltd. engages in providing technology for fusion neutron source to transmute nuclear waste. The company was founded in 2009 and is based in Abingdon, United Kingdom.